Cefmetazole May Be Viable Alternative To Carbapenems For Treatment Of Bacteremia Caused By ESBL-Producing Enterobacterales, Study Finds

Infectious Disease Advisor (11/10, Kuhns) reported, “Cefmetazole may be a viable alternative to carbapenems for the treatment of bacteremia caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacterales, according to study findings published in...